Skip to main content
Clinical Trials/NCT01874717
NCT01874717
Completed
Phase 3

Conscious Sedation With Midazolam in Dentally Anxious Patients: Effect of the Administration Route (Oral Versus Intravenous Administration)

University Hospital, Clermont-Ferrand1 site in 1 country131 target enrollmentJune 2005

Overview

Phase
Phase 3
Intervention
Conscious sedation for dental care
Conditions
Dental Anxiety
Sponsor
University Hospital, Clermont-Ferrand
Enrollment
131
Locations
1
Primary Endpoint
Patient level of cooperation which is assessed using the French modified version of Venham scale
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

Use lay language.

To compare patient level of cooperation during dental care under conscious sedation with midazolam according to the administration route

Detailed Description

The progress of the study is described below: Session 1: intravenous administration of midazolam. Establishment of the individual dose. Randomisation. Session 2 : Group A : oral administration of midazolam : the dose administered is twice the individual dose determined in session 1. Group B : intravenous administration of midazolam at the individual dose determined in session 1. Session 3 : reversal of the procedures : Group A : intravenous administration of midazolam at the individual dose determined in session 1. Group B : oral administration of midazolam : the dose administered is twice the individual dose determined in session 1.

Registry
clinicaltrials.gov
Start Date
June 2005
End Date
August 2007
Last Updated
12 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
University Hospital, Clermont-Ferrand
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • - Patient between 8 and 60 years, regardless of gender
  • Patient in the American Society of Anesthesiologists (ASA) category I ou II.
  • Patient in need of multiple dental care, referred to the Unit of Special Care Dentistry for cooperation difficulties
  • Patients directed to conscious sedation under midazolam because they cannot be approached for more than a very brief examination, or following failure to treat under inhalation sedation (50% N2O/O2), or following poor cooperation during treatment under inhalation sedation (poor cooperation is defined as a score of 3 or more on the French modified version of the Venham scale), or following good cooperation during short and simple treatment under inhalation sedation but in need of more complex rehabilitation.
  • Written consent signed by the patient or his legal guardian
  • Patient accompanied by an accountable person

Exclusion Criteria

  • - Patient below 8 years or over 60 years-old
  • Patient in the American Society of Anesthesiologists (ASA) category III or more
  • Patient having accepted dental treatment without premedication or sedation, and without declaring dental anxiety, during the month prior to the appointment
  • Patient having received an anxiolytic premedication in the 24 hours preceding the dental care session
  • Patient already treated under midazolam sedation less than a week ago
  • Any medical contraindication to the use of midazolam

Arms & Interventions

oral midazolam

oral administration of midazolam : the dose administered is twice the individual dose determined in session 1.

Intervention: Conscious sedation for dental care

oral midazolam

oral administration of midazolam : the dose administered is twice the individual dose determined in session 1.

Intervention: midazolam

intravenous midazolam

intravenous administration of midazolam at the individual dose determined in session 1

Intervention: Conscious sedation for dental care

intravenous midazolam

intravenous administration of midazolam at the individual dose determined in session 1

Intervention: midazolam

Outcomes

Primary Outcomes

Patient level of cooperation which is assessed using the French modified version of Venham scale

Time Frame: During the first dental care procedure (at day 1)

This scale offers a good description of behaviour and anxiety in one score (from0 to 5)

Secondary Outcomes

  • The level of patient stress which is assessed using the French modified version of Venham scale(at T8 (end of dental treatment))
  • Satisfaction level of the patient which is assessed using the French modified version of Venham scale(48 hours after dental care (T14).)
  • Satisfaction level of the accompanying person which is assessed using the French modified version of Venham scale(48 hours after dental care (T14).)
  • Satisfaction level of the operator which is assessed using the French modified version of Venham scale(48 hours after dental care (T14).)

Study Sites (1)

Loading locations...

Similar Trials